A Trial for Patients With Gestational Trophoblastic Disease
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low
risk Gestational Trophoblastic Tumor (GTT) that have failed prior treatment.